CD34-Selected Hematopoietic Stem Cell Transplants Conditioned with Myeloablative Regimens and Antithymocyte Globulin for Advanced Myelodysplastic Syndrome: Limited Graft-versus-Host Disease without Increased Relapse-Reference-Cited by-同舟云学术

CD34-Selected Hematopoietic Stem Cell Transplants Conditioned with Myeloablative Regimens and Antithymocyte Globulin for Advanced Myelodysplastic Syndrome: Limited Graft-versus-Host Disease without Increased Relapse

Published:2015-12 Issue:12 Volume:21 Page:2106-2114
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Tamari Roni,Chung Stephen S.,Papadopoulos Esperanza B.,Jakubowski Ann A.,Hilden Patrick^ORCID,Devlin Sean M.,Goldberg Jenna D.,Perales Miguel-Angel,Ponce Doris M.,Sauter Craig S.,Maloy Molly A.,Herman Dara Y.,Klimek Virginia,Young James W.,O'Reilly Richard J.,Giralt Sergio A.,Castro-Malaspina Hugo

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference55 articles.

1. Clinical effect of point mutations in myelodysplastic syndromes;Bejar;N Engl J Med,2011

2. Clinical and biological implications of driver mutations in myelodysplastic syndromes;Papaemmanuil;Blood,2013

3. Validation of a prognostic model and the impact of mutations in patients with lower-risk myelodysplastic syndromes;Bejar;J Clin Oncol,2012

4. NRAS mutations with low allele burden have independent prognostic significance for patients with lower risk myelodysplastic syndromes;Murphy;Leukemia,2013

5. Clonal architecture of secondary acute myeloid leukemia;Walter;N Engl J Med,2012

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune reconstitution, vaccine responses, and rituximab use after ex-vivo CD34-selected myeloablative allogenic hematopoietic cell transplantation;Bone Marrow Transplantation;2024-02-13

2. Determination of Busulfan and Melphalan in Plasma by Turbulent Flow Chromatography-Tandem Mass Spectrometry;Methods in Molecular Biology;2023-12-01

3. Are We Making PROGRESS in Preventing Graft-versus-Host Disease and Improving Clinical Outcomes? Impact of BMT CTN 1301 Study Results on Clinical Practice;Transplantation and Cellular Therapy;2022-08

4. Fractionated Infusion of Hematopoietic Progenitor Cells Does Not Improve Neutrophil Recovery or Survival in Allograft Recipients;Transplantation and Cellular Therapy;2021-10

5. The Simplified Comorbidity Index (SCI) - a new tool for prediction of non-relapse mortality in allogeneic HCT;Blood Advances;2021-09-10